Program Strategy
- Program Strategy
  We provide comprehensive services to guide you through the development and execution of a program strategy, across all stages of development and life cycle management, for drugs, biologics, and medical devices.
  Overview
Clinical Trials
- Clinical Trials
  Our global solutions leverage decades of focused therapeutic expertise, strong site and investigator relationships and an insider’s understanding of international regulatory landscapes. Rho’s global team of experts ensure consistent trials—traditional, virtual, and hybrid—that run smarter and more efficiently.
Marketing Applications
- Marketing Applications
  Marketing application submissions, including NDAs, BLAs, and MAAs, are the culmination of years of research and the final hurdle before a product makes it to market. Let our integrated team of experts get your product across the finish line.
  Overview
Government Partnerships
Why Rho
- Why Rho
Resources
- Resources
Careers
- Careers

Article

Clinical Trials in Oncology: Key Points to Consider

Cancer is a major cause of death and reduced life expectancy. As per GLOBOCAN reports, in 2020, there were around 19.3 million new cancer cases worldwide, and 10 million people died due to cancer. New cancer cases are estimated to increase to 28.4 million by 2040 – a 47% increase from 2020. These are not just numbers but real human cases – the development of new drugs and treatment regimens for reducing the global disease burden is essential.

Understanding the challenges at all stages is important to carve out solutions and ensure clinical trial success. This article will discuss the key points to consider when conducting oncology clinical trials.